Luminespib

DB11881InvestigationalSmall molecule

AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.

Formula / weight: C₂₇H₃₃N₃O₅ · 479.577 g/mol (avg)
Code names: AUY-922 · NVP-AUY922

Resolves to

Compound

UNIIG1G66XE93WCAS747412-64-2ChEMBLCHEMBL399583PubChem10480258

Structure

InChIKeyWLYWTGDTMWWNNG-UHFFFAOYSA-NSMILESCCNC(=O)C1=NOC(=C1C1=CC=C(CN2CCOCC2)C=C1)C1=CC(=C(O)C=C1O)C(C)(C)C

Targets

P07900HSP90AA1

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

21Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Luminespib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account